Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Anika Therapeutics is a leading US biopharmaceutical company focused on developing and commercializing innovative therapies for joint health, pain management, and regenerative medicine. The company leverages its proprietary hyaluronic acid technology to provide advanced medical products to patients globally, enhancing their quality of life.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Anika Therapeutics is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Anika Therapeutics last reported quarterly earnings on 7/29/2026 (Q2 2026). Earnings per share (EPS) came in at 0.42 USD.
Across its last 3 earnings reports, Anika Therapeutics stock moved by ±12.7% on average the following day. The largest reaction was -18.8% on 04/29/2026; 2 of 3 reactions were positive.
Anika Therapeutics has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.